Delivery Order SPE2DB22D2206-SPE2DB25FKC69
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,095.54 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (30-count supply) on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ramelteon is a prescription sleep aid medication used in the treatment of insomnia, reflecting the Defense...
- This delivery order, valued at $2,751.58, was awarded on September 8, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count packages). The contract represents a non-competitive, firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50 count) with a firm fixed price ceiling value of $2,669.48. This non-set-aside competitive award is scheduled for completion by August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ramelteon 8 mg tablets in unit-dose packaging (50-count) valued at $2,315.08. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $6,147.26 to AmerisourceBergen Drug Corp for Ramelteon 8 mg tablets (50-unit dose packaging) on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (100-count) with a contract value of $2,035.44. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award involves no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ramelteon 8 mg tablets (100-count units) with a contract ceiling value of $3,606.44. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The ultimate completion date is August 14, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,039.56 to AmerisourceBergen Drug Corp for 30 tablets of Ramelteon 8 mg, a medication used to treat insomnia. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,856.49 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ramelteon 8 mg tablets (30-count units) with a ceiling value of $2,269.62. This firm fixed price contract, with an ultimate completion date of June 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured without set-aside designation, reflecting...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC69Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50-count) with a contract ceiling value of $7,347.27. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The ultimate completion date is set for September 26, 2025, and the product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. Ramelteon is a melatonin receptor agonist used primarily for the treatment of insomnia and represents a critical pharmaceutical commodity for military and federal healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally, including the Defense Health Agency and other federal healthcare entities. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal procurement and maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company has demonstrated consistent capability to fulfill federal medical supply requirements through open competition, with delivery orders ranging from minimal to substantial values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/25/25 |